Core Insights - Premarket trading is showing notable activity with significant price movements indicating potential trading opportunities before the market opens [1] Premarket Gainers - Murano Global Investments Plc (MRNO) is up 146% at $3.35 [3] - Kustom Entertainment, Inc. (KUST) is up 34% at $2.84 [3] - Ainos, Inc. (AIMD) is up 34% at $2.32 [3] - Stride, Inc. (LRN) is up 29% at $94.10 [3] - Shuttle Pharmaceuticals Holdings, Inc. (SHPH) is up 18% at $2.40 [3] - Battalion Oil Corporation (BATL) is up 16% at $3.83 [3] - C3.ai, Inc. (AI) is up 15% at $14.58 [3] - Lantronix, Inc. (LTRX) is up 14% at $7.87 [3] - Nextpower Inc. (NXT) is up 13% at $120.00 [3] - High Roller Technologies, Inc. (ROLR) is up 7% at $7.56 [3] Premarket Losers - Flora Growth Corp. (FLGC) is down 34% at $7.20 [4] - TEN Holdings, Inc. (XHLD) is down 29% at $2.47 [4] - Global Interactive Technologies, Inc. (GITS) is down 22% at $3.25 [4] - 5E Advanced Materials, Inc. (FEAM) is down 15% at $2.70 [4] - Vyome Holdings, Inc. (HIND) is down 14% at $2.79 [4] - Altimmune, Inc. (ALT) is down 11% at $5.48 [4] - BiomX Inc. (PHGE) is down 10% at $6.22 [4] - Qorvo, Inc. (QRVO) is down 9% at $74.94 [4] - Nuwellis, Inc. (NUWE) is down 9% at $3.45 [4] - Brenmiller Energy Ltd (BNRG) is down 9% at $2.90 [4]

Group 1: U.S. Stock Market Overview - U.S. stocks exhibited mixed performance, with the Dow Jones index declining over 300 points, down 0.68% to 49,074.36, while the NASDAQ rose 0.56% to 23,732.71 and the S&P 500 increased by 0.23% to 6,966.23 [1] - Information technology shares increased by 0.9%, whereas health care stocks fell by 1% [1] Group 2: General Motors Financial Performance - General Motors reported fourth-quarter adjusted earnings per share of $2.51, reflecting a 30.4% year-over-year increase, surpassing the analyst consensus estimate of $2.20 [2] - Quarterly sales amounted to $45.287 billion, which was below the expected $45.804 billion [2] - The Board of Directors approved a 3 cents per share increase in the quarterly common stock dividend rate to 18 cents per share and authorized a new $6 billion share repurchase program [3] Group 3: Commodity Market Update - Oil prices increased by 1.1% to $61.29, while gold prices decreased by 0.1% to $5,081.50 [4] - Silver prices fell by 3.1% to $111.965, and copper prices dropped by 2% to $5.8995 [4] Group 4: Asian and European Market Performance - Asian markets closed higher, with Japan's Nikkei gaining 0.85%, Hong Kong's Hang Seng Index up 1.35%, China's Shanghai Composite rising 0.18%, and India's BSE Sensex increasing by 0.39% [6] - European shares were mostly higher, with the eurozone's STOXX 600 rising 0.4%, Spain's IBEX 35 Index up 0.3%, and London's FTSE 100 increasing by 0.6% [5]

Group 1: U.S. Stock Market Overview - U.S. stocks traded mixed, with the Dow Jones index falling more than 300 points, down 0.68% to 49,074.36, while the NASDAQ gained 0.56% to 23,732.71 and the S&P 500 rose 0.23% to 6,966.23 [1] - Information technology shares increased by 0.9%, while health care stocks fell by 1% [1] Group 2: General Motors Financial Performance - General Motors reported fourth-quarter adjusted earnings per share of $2.51, a 30.4% year-over-year increase, surpassing the analyst consensus estimate of $2.20 [2] - Quarterly sales reached $45.287 billion, which was below the expected $45.804 billion [2] Group 3: General Motors Corporate Actions - General Motors' Board of Directors approved a 3 cents per share increase in the quarterly common stock dividend rate to 18 cents per share [3] - The company also authorized a new $6 billion share repurchase program [3] Group 4: Commodity Market Update - Oil prices increased by 1.1% to $61.29, while gold prices decreased by 0.1% to $5,081.50 [4] - Silver prices fell by 3.1% to $111.965, and copper prices dropped by 2% to $5.8995 [4] Group 5: European Market Performance - European shares were mostly higher, with the eurozone's STOXX 600 rising by 0.4%, Spain's IBEX 35 Index up by 0.3%, and London's FTSE 100 increasing by 0.6% [5] - Germany's DAX fell by 0.1%, while France's CAC 40 rose by 0.4% [5] Group 6: Asian Market Performance - Asian markets closed higher, with Japan's Nikkei gaining 0.85%, Hong Kong's Hang Seng Index up by 1.35%, China's Shanghai Composite rising by 0.18%, and India's BSE Sensex increasing by 0.39% [6] Group 7: Notable Stock Movements - X3 Holdings Co Ltd shares surged 135% to $0.63 after a 94% increase on Monday [8] - Nuwellis Inc shares rose 112% to $4.56 after a 3% decline on Monday [8] - INVO Fertility Inc shares increased by 64% to $1.98 [8] - Dogness International Corp shares dropped by 44% to $1.50, and Twin Hospitality Group Inc shares fell by 40% to $0.32 after filing for Chapter 11 [8] - FAT Brands Inc shares decreased by 24% to $0.30 after commencing Chapter 11 [8]

At 7:02 a.m. ET on Tuesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening bell.For active traders, premarket trading offers a head start in spotting potential breakouts, reversals, or sharp price swings. These early moves often indicate where momentum may carry into the regular session, making premarket analysis a key part of the trading day. In the Green - Premarket GainersThe following stocks are trading hig ...

Core Insights - Biomx Inc (NYSE:PHGE) shares surged 103.4% to $8.34 in pre-market trading following a 13D filing revealing that Pyu Pyu Capital holds a 19.99% stake in the company [1] Gainers - Nuwellis Inc (NASDAQ:NUWE) increased by 114% to $4.60 in pre-market trading after a 3% decline on Monday [4] - X3 Holdings Co Ltd (NASDAQ:XTKG) rose 84.4% to $0.49 in pre-market trading after a 94% jump on Monday [4] - USBC Inc (NYSE:USBC) gained 64.6% to $0.93 in pre-market trading following a definitive agreement with Uphold and Vast Bank for a tokenized bank deposit initiative [4] - A SPAC III Acquisition Corp (NASDAQ:ASPC) shares increased by 28.4% to $15.84 in pre-market trading after a 12% dip on Monday [4] - Genenta Science SPA (NASDAQ:GNTA) rose 25.4% to $1.63 in pre-market trading after announcing a strategic transformation into a biotech, defense, aerospace, and national security industrial consolidator [4] - China SXT Pharmaceuticals Inc (NASDAQ:SXTC) gained 16.1% to $0.095 in pre-market trading after a 4% decline on Monday [4] - TRX Gold Corp (NYSE:TRX) increased by 11.2% to $1.55 in pre-market trading after a 22% climb on Monday [4] - United Microelectronics Corp (NYSE:UMC) rose 10.3% to $12.50 in pre-market trading after adding over 7% on Monday [4] - Hyperliquid Strategies Inc (NASDAQ:PURR) gained 9.9% to $4.11 in pre-market trading after a jump of over 6% on Monday [4] Losers - FAT Brands Inc (NASDAQ:FAT) fell 48.5% to $0.20 in pre-market trading after commencing Chapter 11 to reinforce its financial foundation [4] - MDJM Ltd (NASDAQ:UOKA) dipped 38.3% to $1.37 in pre-market trading following an announcement of an offering of 2,336,448 units [4] - Brand Engagement Network Inc (NASDAQ:BNAI) declined 32.1% to $42.15 in pre-market trading after a 277% jump on Monday [4] - AVAX One Technology Ltd (NASDAQ:AVX) shares dipped 27.7% to $1.25 in pre-market trading after a 7% decline on Monday [4] - Twin Hospitality Group Inc (NASDAQ:TWNP) fell 27.1% to $0.39 in pre-market trading after filing voluntary Chapter 11 petitions [4] - Tian Ruixiang Holdings Ltd (NASDAQ:TIRX) tumbled 20.1% to $0.35 in pre-market trading after receiving a Nasdaq delisting notification [4] - Dogness International Corp (NASDAQ:DOGZ) declined 19.6% to $2.17 in pre-market trading after a 76% dip on Monday [4] - Battalion Oil Corp (NYSE:BATL) fell 19.6% to $3.24 in pre-market trading after a 215% gain on Monday [4] - Humana Inc (NYSE:HUM) decreased by 12.2% to $231.39 in pre-market trading following a report on unchanged Medicare insurer rates [4] - Alignment Healthcare Inc (NASDAQ:ALHC) dipped 11.8% to $21.00 in pre-market trading, also influenced by the same Medicare report [4]

Earnings Reports Overview - The earnings season is slowing down, but several retail-favorite companies are set to report this week [1] - Key companies reporting include Barrick Mining Corp., Plug Power Inc., Oklo Inc., Cisco Systems Inc., Walt Disney Co., and Applied Materials Inc. [2][3][5][10][11] Company-Specific Insights - Barrick Mining Corp. reported its third-quarter results before the market opened on November 10 [2] - Plug Power Inc. is expected to report losses of 12 cents per share and revenue of $179.54 million, having missed earnings expectations for the last 18 quarters [3] - Oklo Inc. is anticipated to report losses of 13 cents per share and revenue of $17.01 billion, with stock volatility noted ahead of the report [5] - Cisco Systems Inc. is expected to be a focal point for investors, particularly regarding management's guidance and updates on AI and cybersecurity business momentum [10] - Walt Disney Co. and JD.com Inc. will release earnings reports before the market opens on November 13 [11] - Applied Materials Inc. is set to release its Q4 results after the market closes on November 13 [11] Additional Companies Reporting - Other companies reporting this week include Workhorse Group Inc., Beyond Meat Inc., Microvision Inc., and Virgin Galactic Holdings Inc. [4][6][12]

U.S. stock futures were mostly lower this morning, with the Dow futures falling around 0.2% on Thursday.Shares of Abbott Laboratories ABT fell sharply in pre-market trading after the company issued third-quarter adjusted EPS guidance below estimates.Abbott posted adjusted earnings of $1.26 per share, beating market estimates of $1.25 per share. The company's sales came in at $11.142 billion versus expectations of $11.068 billion.Abbott Laboratories said it sees third-quarter adjusted EPS of $1.28 to $1.32, ...

Market Overview - U.S. stocks traded higher, with the Dow Jones index gaining over 100 points, up 0.25% to 44,133.80, NASDAQ rose 0.09% to 20,696.02, and S&P 500 increased 0.12% to 6,251.54 [1] - Health care shares jumped by 1.2%, while energy stocks dipped by 0.3% [1] Company Performance - Goldman Sachs Group Inc. reported second-quarter results that exceeded analyst expectations, with net revenue rising 15% year over year to $14.58 billion, surpassing the consensus estimate of $13.36 billion, although it declined 3% from the prior quarter [2] - GAAP earnings for Goldman Sachs came in at $10.91 per share, up from $8.62 a year ago and above the $9.48 consensus, with first-half EPS rising to $25.07 from $20.21 a year earlier [2] Stock Movements - Aptorum Group Limited shares surged 256% to $3.45 following an all-stock merger agreement with DiamiR [8] - Nuwellis, Inc. shares increased by 121% to $15.25 after securing a U.S. patent for a blood filtering machine [8] - Rigetti Computing, Inc. shares rose 30% to $16.59 after unveiling the largest multi-chip quantum computer in the industry [8] - Soluna Holdings, Inc. shares dropped 28% to $0.5481 after announcing a $5 million public offering [8] - ASML Holding N.V. shares fell 9% to $748.09 due to concerns over 2026 growth prospects [8] - Onconetix, Inc. shares decreased by 22% to $3.5150 following a merger agreement with Ocuvex Therapeutics [8] Commodity Prices - Oil traded down 0.5% to $66.18, while gold increased by 0.7% to $3,358.70 [5] - Silver fell 0.1% to $38.085, and copper decreased by 0.9% to $5.53 [5] Economic Indicators - U.S. crude oil inventories declined by 3.859 million barrels in the week ended July 11 [11] - U.S. industrial production increased by 0.3% in June, exceeding market estimates of a 0.1% rise [11] - U.S. producer prices remained unchanged in June from May, compared to a revised 0.3% gain in the previous period [11]

Market Overview - U.S. stocks showed mixed trading with the Nasdaq down approximately 0.1% on Wednesday [1] - The Dow Jones increased by 0.08% to 44,060.17, while the S&P 500 rose by 0.03% to 6,245.49 [1] Sector Performance - Health care shares experienced a rise of 1.2% on Wednesday [1] - Energy stocks saw a decline of 0.8% [1] Company Earnings - Bank of America Corp reported second-quarter fiscal 2025 net income of $7.1 billion, up from $6.9 billion a year ago, with EPS of $0.89, surpassing the analyst consensus estimate of $0.87 [2] - Revenue for Bank of America increased by 4% year-over-year to $26.5 billion, although it fell short of the analyst consensus estimate of $26.8 billion [2] Commodity Prices - Oil prices decreased by 1.1% to $65.81, while gold prices increased by 0.3% to $3,347.00 [4] - Silver prices fell by 0.2% to $38.035, and copper prices dropped by 1.6% to $5.49 [4] Asian Market Performance - Asian markets closed mixed, with Japan's Nikkei down 0.04% and Hong Kong's Hang Seng down 0.29% [6] - China's Shanghai Composite also fell by 0.04%, while India's BSE Sensex gained 0.08% [6] Notable Stock Movements - Aptorum Group Limited shares surged by 254% to $3.4413 following an all-stock merger agreement with DiamiR [8] - Nuwellis, Inc. shares increased by 140% to $16.58 after securing a U.S. patent for a blood filtering machine [8] - Barinthus Biotherapeutics plc shares rose by 92% to $1.96 [8] - Soluna Holdings, Inc. shares dropped by 33% to $0.5083 after announcing a $5 million public offering [8] - Cyclacel Pharmaceuticals, Inc. shares fell by 25% to $9.20, and Onconetix, Inc. shares decreased by 22% to $3.5150 following a merger announcement [8] Economic Indicators - U.S. crude oil inventories declined by 3.859 million barrels for the week ended July 11 [9] - U.S. industrial production increased by 0.3% in June, exceeding market estimates of a 0.1% rise [9] - U.S. producer prices remained unchanged in June compared to May, contrasting with a revised 0.3% gain in the previous period [10]

Financial Data and Key Metrics Changes - Nuwellis generated $2.3 million in revenue for Q4 2024, a 9% decrease year-over-year due to a decline in U.S. console sales and international sales, offset by a 21% increase in consumables utilization [10][20] - Gross margin improved to 58.4% for Q4 2024 compared to 54.4% in the prior year quarter, driven by higher manufacturing volumes of consumables and lower fixed overhead manufacturing expenses [21] - Net loss attributable to common shareholders in Q4 was $1.5 million, or a loss of $0.44 per share, compared to a net loss of $7.9 million, or a loss of $54.48 per share for the same period in 2023 [24][25] Business Line Data and Key Metrics Changes - The Critical Care business, the largest customer category, saw a 35% year-over-year quarterly revenue growth, benefiting from higher console sales and consumable utilization [11][20] - Heart failure and pediatric customer categories experienced declines of 36% and 20% respectively due to lower console sales [12][20] Market Data and Key Metrics Changes - The company reported nine new account wins throughout 2024, indicating positive market penetration [9] - A favorable reimbursement change effective January 1, 2025, allows Nuwellis to enter the outpatient services market for Aquadex technology, with the facility reimbursement fee increasing nearly fourfold from $413 to $1,639 per day [14][15] Company Strategy and Development Direction - Nuwellis aims to build its body of clinical evidence to make Aquadex Ultrafiltration therapy a standard of care and integrate it into medical society guidelines [12] - The company is focused on driving market penetration of Aquadex Ultrafiltration therapy, leveraging clinical evidence and increased reimbursement rates in the outpatient setting [16] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism for 2025, highlighting the positive impact of new account wins and reimbursement changes on growth [9] - The recent publication in JACC: Heart Failure demonstrated a 60% reduction in heart failure events for patients treated with Aquadex compared to traditional IV diuretics, which is expected to support broader adoption of the technology [13][18] Other Important Information - The company had a voluntary recall of specific lots of blood circuit units, which resulted in a non-recurring expense of approximately $150,000 [22] - Total operating expenses decreased by approximately 25% compared to Q4 2023, reflecting savings from operational efficiency initiatives [24] Q&A Session Summary Question: Initial traction in the outpatient setting for Aquadex - Management noted that traction is beginning with several existing accounts needing to set up permanent outpatient facilities, with more activity expected in the coming month [29] Question: Number of Aquadex units sold in Q4 2024 and Q3 2024 - Three units were sold in Q4 2024, compared to 11 units in Q3 2024 [33][35] Question: Timing for reverse HF trial enrollment completion - Management indicated it is difficult to gauge the timing for enrollment completion [37] Question: Timing for the start of the Vivian clinical trial - Management provided a similar response, stating it is difficult to predict [39] Question: Changes in leadership and search for a new CEO - Management confirmed that a search firm has been hired and candidates are being evaluated, with no immediate need for major changes in direction [46]